Concepts (230)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetes, Gestational | 44 | 2024 | 1242 | 10.960 |
Why?
|
Glucose Intolerance | 7 | 2024 | 580 | 2.840 |
Why?
|
Glucose Tolerance Test | 21 | 2024 | 1175 | 2.530 |
Why?
|
Blood Glucose | 20 | 2024 | 6381 | 2.120 |
Why?
|
Insulin Resistance | 12 | 2024 | 3959 | 1.880 |
Why?
|
Pregnancy | 67 | 2024 | 29749 | 1.770 |
Why?
|
Postpartum Period | 7 | 2024 | 1167 | 1.760 |
Why?
|
Vitamin D-Binding Protein | 5 | 2014 | 131 | 1.550 |
Why?
|
Birth Weight | 7 | 2024 | 2097 | 1.290 |
Why?
|
Glucose | 8 | 2024 | 4351 | 1.120 |
Why?
|
Insulin | 11 | 2024 | 6597 | 0.960 |
Why?
|
Pregnancy Trimester, First | 6 | 2022 | 908 | 0.940 |
Why?
|
Pre-Eclampsia | 10 | 2022 | 1229 | 0.920 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2024 | 125 | 0.890 |
Why?
|
Placenta | 5 | 2024 | 1702 | 0.860 |
Why?
|
Hypertension, Pregnancy-Induced | 3 | 2024 | 518 | 0.780 |
Why?
|
Pregnancy Trimester, Third | 3 | 2019 | 582 | 0.780 |
Why?
|
Diabetes Mellitus, Type 2 | 11 | 2024 | 12293 | 0.770 |
Why?
|
Metformin | 4 | 2024 | 912 | 0.770 |
Why?
|
Pregnancy Complications | 5 | 2021 | 2942 | 0.710 |
Why?
|
Vitamin D | 6 | 2015 | 3291 | 0.710 |
Why?
|
Serum Albumin | 1 | 2023 | 674 | 0.700 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2024 | 516 | 0.650 |
Why?
|
Carbohydrate Metabolism | 1 | 2020 | 262 | 0.650 |
Why?
|
Prolactin | 2 | 2011 | 621 | 0.630 |
Why?
|
Fetal Macrosomia | 3 | 2024 | 131 | 0.610 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2022 | 377 | 0.600 |
Why?
|
Parathyroid Hormone | 4 | 2015 | 1797 | 0.600 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2021 | 389 | 0.590 |
Why?
|
Milk, Human | 3 | 2011 | 483 | 0.580 |
Why?
|
Metabolic Diseases | 1 | 2023 | 686 | 0.550 |
Why?
|
Female | 78 | 2024 | 391270 | 0.540 |
Why?
|
Dietary Carbohydrates | 1 | 2021 | 892 | 0.530 |
Why?
|
Hypoglycemia | 4 | 2024 | 888 | 0.530 |
Why?
|
Gestational Age | 8 | 2024 | 3565 | 0.530 |
Why?
|
Infertility | 1 | 2022 | 655 | 0.510 |
Why?
|
Pregnancy Outcome | 10 | 2024 | 2907 | 0.500 |
Why?
|
Lactation Disorders | 2 | 2011 | 14 | 0.470 |
Why?
|
Genotype | 5 | 2021 | 12960 | 0.440 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2020 | 15789 | 0.440 |
Why?
|
Humans | 83 | 2024 | 760621 | 0.380 |
Why?
|
Genetic Loci | 1 | 2020 | 2618 | 0.370 |
Why?
|
Glucokinase | 2 | 2021 | 102 | 0.360 |
Why?
|
Genetic Predisposition to Disease | 3 | 2020 | 17790 | 0.330 |
Why?
|
Adult | 42 | 2024 | 219994 | 0.330 |
Why?
|
Cardiovascular Diseases | 3 | 2024 | 15757 | 0.330 |
Why?
|
Hyperglycemia | 3 | 2024 | 1380 | 0.320 |
Why?
|
Premature Birth | 6 | 2024 | 1771 | 0.280 |
Why?
|
Parity | 2 | 2021 | 925 | 0.260 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 4 | 2013 | 558 | 0.250 |
Why?
|
Risk Factors | 19 | 2024 | 74359 | 0.250 |
Why?
|
Prenatal Exposure Delayed Effects | 2 | 2023 | 2496 | 0.250 |
Why?
|
Diabetes Mellitus, Type 1 | 3 | 2024 | 3455 | 0.240 |
Why?
|
Hyperbilirubinemia, Neonatal | 1 | 2024 | 31 | 0.230 |
Why?
|
Pregnancy Trimester, Second | 3 | 2021 | 732 | 0.220 |
Why?
|
Diabetic Nephropathies | 1 | 2011 | 988 | 0.220 |
Why?
|
Hypoglycemic Agents | 4 | 2024 | 3150 | 0.220 |
Why?
|
Diabetes Mellitus | 4 | 2023 | 5889 | 0.220 |
Why?
|
Biological Availability | 3 | 2013 | 395 | 0.220 |
Why?
|
Prospective Studies | 12 | 2024 | 54303 | 0.220 |
Why?
|
Infant, Small for Gestational Age | 2 | 2024 | 460 | 0.220 |
Why?
|
Longitudinal Studies | 4 | 2022 | 14495 | 0.220 |
Why?
|
Pregnancy Proteins | 3 | 2013 | 222 | 0.210 |
Why?
|
Pregnancy in Diabetics | 1 | 2024 | 194 | 0.210 |
Why?
|
Burnout, Professional | 2 | 2022 | 702 | 0.210 |
Why?
|
Mediastinum | 1 | 2024 | 266 | 0.210 |
Why?
|
Infant, Newborn | 11 | 2024 | 26181 | 0.200 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 2024 | 227 | 0.200 |
Why?
|
Bone Density | 2 | 2013 | 3534 | 0.200 |
Why?
|
Neovascularization, Pathologic | 2 | 2013 | 2640 | 0.200 |
Why?
|
Intensive Care Units, Neonatal | 3 | 2024 | 833 | 0.190 |
Why?
|
Lipid Metabolism | 2 | 2020 | 1902 | 0.190 |
Why?
|
Peripartum Period | 1 | 2022 | 138 | 0.180 |
Why?
|
Diabetic Ketoacidosis | 1 | 2024 | 257 | 0.180 |
Why?
|
Stillbirth | 1 | 2024 | 368 | 0.180 |
Why?
|
Asthma | 3 | 2023 | 6172 | 0.170 |
Why?
|
Young Adult | 14 | 2024 | 58741 | 0.170 |
Why?
|
Leptin | 2 | 2019 | 1591 | 0.170 |
Why?
|
Labor, Obstetric | 1 | 2023 | 321 | 0.170 |
Why?
|
Retrospective Studies | 13 | 2024 | 80372 | 0.160 |
Why?
|
Endothelium, Vascular | 1 | 2011 | 4433 | 0.160 |
Why?
|
Pilot Projects | 3 | 2023 | 8555 | 0.160 |
Why?
|
Infant, Newborn, Diseases | 1 | 2024 | 592 | 0.160 |
Why?
|
Cohort Studies | 7 | 2024 | 41335 | 0.160 |
Why?
|
Fetal Development | 1 | 2024 | 766 | 0.150 |
Why?
|
Fetal Blood | 2 | 2023 | 1343 | 0.150 |
Why?
|
Body Mass Index | 7 | 2024 | 12914 | 0.150 |
Why?
|
Case-Control Studies | 7 | 2022 | 22053 | 0.140 |
Why?
|
Bronchiolitis | 1 | 2023 | 481 | 0.140 |
Why?
|
Fetus | 2 | 2021 | 1859 | 0.140 |
Why?
|
C-Peptide | 1 | 2018 | 433 | 0.140 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2019 | 4357 | 0.140 |
Why?
|
Pregnant Women | 1 | 2021 | 563 | 0.130 |
Why?
|
Cardiovascular System | 1 | 2024 | 850 | 0.130 |
Why?
|
Hyperinsulinism | 1 | 2019 | 402 | 0.130 |
Why?
|
Massachusetts | 4 | 2020 | 8803 | 0.130 |
Why?
|
DNA Methylation | 2 | 2021 | 4373 | 0.130 |
Why?
|
24,25-Dihydroxyvitamin D 3 | 1 | 2015 | 8 | 0.130 |
Why?
|
Linear Models | 3 | 2021 | 5877 | 0.130 |
Why?
|
Kidney | 1 | 2011 | 7064 | 0.120 |
Why?
|
Acute Kidney Injury | 2 | 2018 | 1941 | 0.120 |
Why?
|
Celiac Disease | 1 | 2023 | 822 | 0.120 |
Why?
|
Physicians, Women | 1 | 2020 | 495 | 0.120 |
Why?
|
Eating | 1 | 2021 | 1539 | 0.120 |
Why?
|
Medicine | 1 | 2022 | 943 | 0.110 |
Why?
|
Cluster Analysis | 1 | 2020 | 2698 | 0.110 |
Why?
|
Kidney Calculi | 1 | 2018 | 468 | 0.110 |
Why?
|
Renal Dialysis | 2 | 2012 | 1801 | 0.100 |
Why?
|
United States | 12 | 2024 | 72461 | 0.090 |
Why?
|
Gene Expression Profiling | 2 | 2024 | 9411 | 0.090 |
Why?
|
Internship and Residency | 2 | 2022 | 5870 | 0.090 |
Why?
|
Cross-Sectional Studies | 7 | 2024 | 25942 | 0.090 |
Why?
|
Patient Satisfaction | 1 | 2023 | 3448 | 0.090 |
Why?
|
Adiponectin | 1 | 2017 | 1115 | 0.090 |
Why?
|
Recombinant Proteins | 2 | 2011 | 6538 | 0.090 |
Why?
|
Heart | 1 | 2024 | 4393 | 0.090 |
Why?
|
Sequence Analysis, DNA | 1 | 2021 | 4713 | 0.090 |
Why?
|
Blood Pressure | 3 | 2018 | 8525 | 0.090 |
Why?
|
Blood Glucose Self-Monitoring | 2 | 2024 | 457 | 0.090 |
Why?
|
Cardiomyopathies | 1 | 2022 | 1952 | 0.090 |
Why?
|
Follistatin-Related Proteins | 1 | 2009 | 48 | 0.090 |
Why?
|
Fasting | 1 | 2016 | 1603 | 0.090 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2011 | 278 | 0.080 |
Why?
|
Apolipoproteins | 1 | 2011 | 320 | 0.080 |
Why?
|
Kidney Failure, Chronic | 2 | 2012 | 2471 | 0.080 |
Why?
|
Environmental Exposure | 1 | 2024 | 4412 | 0.080 |
Why?
|
Breast Neoplasms | 1 | 2016 | 21025 | 0.080 |
Why?
|
National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) | 2 | 2018 | 26 | 0.080 |
Why?
|
Homozygote | 1 | 2013 | 1788 | 0.080 |
Why?
|
Mass Screening | 2 | 2022 | 5423 | 0.080 |
Why?
|
Chromosome Disorders | 1 | 2011 | 499 | 0.080 |
Why?
|
Bone Remodeling | 1 | 2012 | 580 | 0.080 |
Why?
|
Multivariate Analysis | 2 | 2019 | 12159 | 0.070 |
Why?
|
Risk | 3 | 2022 | 9631 | 0.070 |
Why?
|
Lipoproteins, HDL | 1 | 2011 | 667 | 0.070 |
Why?
|
Incidence | 5 | 2018 | 21392 | 0.070 |
Why?
|
Parturition | 2 | 2023 | 446 | 0.070 |
Why?
|
Reproducibility of Results | 2 | 2022 | 20080 | 0.070 |
Why?
|
Vitamin D Deficiency | 2 | 2015 | 1379 | 0.070 |
Why?
|
Population Surveillance | 1 | 2016 | 2608 | 0.070 |
Why?
|
CpG Islands | 2 | 2021 | 1221 | 0.060 |
Why?
|
Schools, Medical | 1 | 2012 | 878 | 0.060 |
Why?
|
Physicians, Primary Care | 1 | 2012 | 624 | 0.060 |
Why?
|
Genome-Wide Association Study | 2 | 2024 | 12626 | 0.060 |
Why?
|
Male | 13 | 2024 | 359744 | 0.060 |
Why?
|
Cytokines | 1 | 2019 | 7343 | 0.060 |
Why?
|
Physicians | 1 | 2022 | 4591 | 0.060 |
Why?
|
Faculty, Medical | 1 | 2012 | 1192 | 0.060 |
Why?
|
Health Surveys | 1 | 2013 | 4063 | 0.060 |
Why?
|
Risk Assessment | 2 | 2018 | 24123 | 0.050 |
Why?
|
Polymorphism, Genetic | 1 | 2013 | 4291 | 0.050 |
Why?
|
Diet | 1 | 2021 | 8010 | 0.050 |
Why?
|
Biomedical Research | 1 | 2018 | 3426 | 0.050 |
Why?
|
Age Factors | 1 | 2019 | 18416 | 0.050 |
Why?
|
Hypertension | 2 | 2014 | 8594 | 0.050 |
Why?
|
Boston | 3 | 2024 | 9280 | 0.050 |
Why?
|
Africa, Northern | 1 | 2021 | 86 | 0.050 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12531 | 0.050 |
Why?
|
Lumbar Vertebrae | 1 | 2011 | 1868 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2010 | 6238 | 0.050 |
Why?
|
Bone and Bones | 1 | 2012 | 2560 | 0.050 |
Why?
|
Middle East | 1 | 2021 | 230 | 0.050 |
Why?
|
Obesity | 2 | 2023 | 12922 | 0.050 |
Why?
|
Infant, Premature | 1 | 2010 | 2092 | 0.050 |
Why?
|
Endocrine Disruptors | 1 | 2024 | 263 | 0.050 |
Why?
|
Lipids | 2 | 2023 | 3336 | 0.040 |
Why?
|
KCNQ1 Potassium Channel | 1 | 2019 | 103 | 0.040 |
Why?
|
Africa | 1 | 2021 | 705 | 0.040 |
Why?
|
Infant | 3 | 2023 | 36060 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2024 | 1722 | 0.040 |
Why?
|
Sex Characteristics | 1 | 2010 | 2629 | 0.040 |
Why?
|
Comparative Effectiveness Research | 1 | 2024 | 718 | 0.040 |
Why?
|
Live Birth | 1 | 2022 | 512 | 0.040 |
Why?
|
Students, Medical | 1 | 2012 | 1927 | 0.040 |
Why?
|
Policy | 1 | 2022 | 511 | 0.040 |
Why?
|
Fetal Growth Retardation | 1 | 2022 | 579 | 0.040 |
Why?
|
Genomic Imprinting | 1 | 2019 | 330 | 0.040 |
Why?
|
Maternal Exposure | 1 | 2024 | 1045 | 0.040 |
Why?
|
Double-Blind Method | 1 | 2011 | 12427 | 0.030 |
Why?
|
Patient Preference | 1 | 2023 | 922 | 0.030 |
Why?
|
Middle Aged | 6 | 2016 | 220352 | 0.030 |
Why?
|
Kidney Transplantation | 1 | 2011 | 4215 | 0.030 |
Why?
|
Maternal Age | 1 | 2018 | 807 | 0.030 |
Why?
|
Primary Health Care | 1 | 2012 | 4647 | 0.030 |
Why?
|
Databases, Factual | 1 | 2011 | 8035 | 0.030 |
Why?
|
Haplotypes | 1 | 2021 | 2764 | 0.030 |
Why?
|
Minority Groups | 1 | 2022 | 1201 | 0.030 |
Why?
|
Mendelian Randomization Analysis | 1 | 2019 | 998 | 0.030 |
Why?
|
Cesarean Section | 1 | 2023 | 1385 | 0.030 |
Why?
|
Consensus | 1 | 2023 | 3113 | 0.030 |
Why?
|
Mothers | 1 | 2024 | 2186 | 0.030 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2022 | 1717 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2018 | 1180 | 0.030 |
Why?
|
Pedigree | 1 | 2020 | 4578 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2023 | 3696 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2021 | 2717 | 0.020 |
Why?
|
Prevalence | 2 | 2021 | 15687 | 0.020 |
Why?
|
Prenatal Care | 1 | 2018 | 1129 | 0.020 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2011 | 193 | 0.020 |
Why?
|
Child | 3 | 2023 | 79806 | 0.020 |
Why?
|
Patient Admission | 1 | 2018 | 1386 | 0.020 |
Why?
|
Life Style | 1 | 2022 | 3896 | 0.020 |
Why?
|
Child, Preschool | 2 | 2023 | 42063 | 0.020 |
Why?
|
Trisomy | 1 | 2011 | 260 | 0.020 |
Why?
|
Diagnostic Techniques, Endocrine | 1 | 2009 | 43 | 0.020 |
Why?
|
Decision Making | 1 | 2023 | 3925 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2018 | 2180 | 0.020 |
Why?
|
Systole | 1 | 2012 | 947 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2015 | 1189 | 0.020 |
Why?
|
Macrophages | 1 | 2023 | 5745 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2014 | 2932 | 0.020 |
Why?
|
Adolescent | 3 | 2022 | 87810 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2019 | 4407 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2022 | 3388 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2020 | 12965 | 0.010 |
Why?
|
Age of Onset | 1 | 2011 | 3301 | 0.010 |
Why?
|
Hospitalization | 1 | 2024 | 10790 | 0.010 |
Why?
|
ROC Curve | 1 | 2012 | 3568 | 0.010 |
Why?
|
MicroRNAs | 1 | 2019 | 3790 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2011 | 2825 | 0.010 |
Why?
|
Odds Ratio | 1 | 2014 | 9716 | 0.010 |
Why?
|
Antigens, CD | 1 | 2011 | 4000 | 0.010 |
Why?
|
Calcium | 1 | 2012 | 5725 | 0.010 |
Why?
|
Logistic Models | 1 | 2012 | 13314 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39261 | 0.010 |
Why?
|
Genetic Variation | 1 | 2011 | 6551 | 0.010 |
Why?
|
Aged | 2 | 2012 | 169152 | 0.010 |
Why?
|
Prognosis | 1 | 2009 | 29658 | 0.010 |
Why?
|
Time Factors | 1 | 2009 | 40165 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2011 | 58995 | 0.000 |
Why?
|
Concepts
(230)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(87)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_